miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

By Shanshan Zhou, Jingpeng Jin, Ji-qun Wang, Zhiguo Zhang, J. Freedman, Yang Zheng, L. Cai. Acta Pharmacologica Sinica, 2018

602 citations recorded by the source corpus.

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the world. Although considerable progress has been made in the diagnosis, treatment and prognosis of CVD, there is still a critical need for novel diagnostic biomarkers and new therapeutic interventions to decrease the incidence of this disease. Recently, there is increasing evidence that circulating miRNAs (miRNAs), i.e. endogenous, stable, single-stranded, short, non-coding RNAs, can be used as diagnostic biomarkers for CVD. Furthermore, miRNAs represent potential novel therapeutic targets for several cardiovascular disorders. In this review we provides an overview of the effects of several CVD; including heart failure, acute myocardial infarction, arrhythmias and pulmonary hypertension; on levels of circulating miRNAs. In addition, the use of miRNA as therapeutic targets is also discussed, as well as challenges and recommendations in their use in the diagnosis of CVD.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/4dbd1d52a91c7afdb24c9841db598fa124efd951

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. O. Bugnar
  2. M. Barbu
  3. C. Condrat
  4. D. Thompson
  5. S. Voinea
  6. A. Boboc
  7. S. Crețoiu
  8. N. Suciu

Citations in the corpus